|
Inter-Society Coordinating Committee (ISCC) for Practitioner Education in Genomics
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NHGRI, NCI, NEI, NHLBI, NIAAA, NIAID, NIAMS, NICHD, NIDA, NIDCD, NIDCR, NIGMS, NIMH, NINDS, NINR, NLM
|
This education collaborative facilitates sharing interactions among professional societies, agencies, and health systems. It intends to enhance the accrual of knowledge and skill among practitioners applying genomic results to clinical care. In its start-up phase, the ISCC focused primarily on physicians and dentists. It has since expanded to engage and collaborate with allied practitioner groups such as nurse practitioners, physician assistants, pharmacists, genetic counselors, and nurses comprising integrated health care teams. It will continue to add other relevant professions and add to the reviewed and searchable educational resources on its website.
|
|
Interagency Agreement for Communications on Prevention of Underage Tobacco Use
|
Public Education Campaign
|
FDA
|
NCI
|
The FDA Center for Tobacco Products (CTP) and the NCI Office of Communications and Education are collaborating on an Interagency Agreement in which CTP will provide funds to NCI to provide planning, formative research, target messaging, creative content, outreach strategies, and communications support for a campaign to prevent underage tobacco use as it relates to FDA’s authorities under the Tobacco Control Act. Primary focus areas include multi-ethnic journalist training and outreach; development of a partnership strategy, digital strategy, and social marketing tools; digital gaming best practices; and formation of a CTP communications workgroup comprised of subject matter experts.
|
|
Interagency Artificial Pancreas Working Group
|
Committee, Work group, Advisory group, or Task Force
|
FDA
|
NIDDK, NIBIB, NICHD
|
The Interagency Artificial Pancreas Working Group is a group of multi-disciplined scientists and clinicians from the Food and Drug Administration (FDA) and the NIH to support the Artificial Pancreas Initiative. The goals of this initiative are to provide infrastructure for narrowing the gap between basic biomedical knowledge and clinical application of novel technologies, and to cross-fertilize and partner with stakeholders in order to identify and overcome the clinical and scientific challenges to the development of an artificial pancreas. Through collaborative efforts, such as workshops, the group strives to develop innovative strategies to achieve their goals.
|
|
Interagency Autism Coordinating Committee (IACC)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, ACL, AHRQ, CDC, CMS, FDA, HRSA
|
NIMH, NICHD, NIDCD, NIEHS, NINDS
|
The Interagency Autism Coordinating Committee (IACC) is a Federal advisory committee that coordinates all efforts within the Department of Health and Human Services (HHS) concerning autism spectrum disorder (ASD). Through its inclusion of both Federal and public members, the IACC helps to ensure that a wide range of ideas and perspectives are represented and discussed in a public forum. The committee reconvened in November 2015 to begin a new session under the Autism CARES Act.
|
|
Interagency Biorisk Management Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, FDA, OS
|
OD/OSP, NIAID
|
This working group coordinates and collaborates on mechanisms to strengthen research laboratory bio-risk management and to promote outreach and education programs that inform scientists, biosafety professionals, institutional officials, and the public on bio-risk management.
|
|
Interagency Chemical Risk Assessment Working Group
|
Committee, Work group, Advisory group, or Task Force
|
OS
|
NINDS, NIAID
|
This working group is a Department of Homeland Security led effort to determine chemical hazards and develop Chemical Risk Threat Assessment list of priority chemicals.
|
|
Interagency Collaborative Animal Research Education (ICARE) Training Project
|
Training Initiative
|
BARDA, FDA
|
OD/OER
|
The Interagency Collaborative Animal Research Education (ICARE) Academies and Train the Trainer Institutes use active learning to train participants to meet their responsibilities for animal welfare oversight. The program empowers accountability for facts and conceptual understanding of Federal standards through the study of realistic problems encountered in animal care and use programs. Faculty includes subject matter experts from biomedical research institutions and federal agencies, including NIH and USDA. Institutional Animal Care and Use Committee members, staff, institutional officials, veterinarians, animal facility personnel, administrators, consultants, as well as compliance and regulatory personnel involved in the humane use of animals in research all may participate in the ICARE program.
|
|
Interagency Collaborative to Advance Research in Epilepsy (ICARE)
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA, OS
|
NINDS, FIC, NCATS, NHGRI, NHLBI, NIA, NIAAA, NIAMS, NICHD, NIDA, NIMH
|
The Interagency Collaborative to Advance Research in Epilepsy (ICARE) is an interagency epilepsy working group that includes broad representation across the NIH ICs involved in epilepsy-related research, as well as across HHS and other Federal agencies and multiple epilepsy research and patient advocacy groups with a primary focus on biomedical research. The purpose of this group, which is led by the National Institute of Neurological Disorders and Stroke, is to increase communication among institutes and agencies sponsoring epilepsy-related research and to explore opportunities for increased coordination. The group’s annual meetings provide a forum for sharing information about ongoing and planned epilepsy research activities, highlighting advances, discussing needs and opportunities, and promoting increased collaboration toward common research goals.
|
|
Interagency Committee on Disability Research (ICDR)
|
Committee, Work group, Advisory group, or Task Force
|
ACF, AHRQ, ATSDR, CDC, CMS, FDA, HRSA, IHS, OS, OSG, SAMHSA
|
NIDCD
|
The Interagency Committee on Disability Research (ICDR) was established to promote coordination and collaboration among federal departments and agencies conducting disability, independent living, and rehabilitation research programs—including programs related to assistive technology research, and research that incorporates the principles of universal design.
|
|
Interagency Committee on Smoking and Health
|
Committee, Work group, Advisory group, or Task Force
|
CDC, CMS, FDA, HRSA, SAMHSA
|
NIDA, NCI
|
The Committee was chartered in 1985 and advises the Secretary, Department of Health and Human Services (DHHS), the Assistant Secretary for Health, and the Centers for Disease Control and Prevention on coordination of research, educational programs, and other activities within the Department that relate to the effect of smoking on human health, and on coordination of these activities with other Federal, State, local, and private agencies. The Committee established and maintains a liaison with appropriate private entities, other Federal agencies, and State and local public agencies respecting activities relating to the effect of cigarette smoking on human health.
|